ロード中...
Thyromimetics: What does the future hold?
Thyromimetic agents that can treat dyslipidemia without adverse effects like cardiac arrhythmias and osteoporosis are attractive options. Initial experience with desssicated thyroid hormone extract and DT4 were disappointing. Thyroid hormone has nuclear action with four receptor isoforms- TR α1, TRα...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3603016/ https://ncbi.nlm.nih.gov/pubmed/23565368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.104029 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|